Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OM Pharma logo — Transforming Immune Health

OM Pharma

Transforming Immune Health

Founded 1937 Switzerland Meyrin, Switzerland 557 employees Biopharma, Biotechnology +1

General Information

Company Name OM Pharma
Founded Year 1937
Location Switzerland Meyrin, Switzerland +3
Founders / Decision Makers
Team member Team member
Employees 557
Industries Biopharma, Biotechnology, Pharmaceutical
Social

Get notified when OM Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OM Pharma

OM Pharma is a company focused on transforming immune health through its expertise in bacterial lysates. Since its establishment in 1937, the company has been addressing global health challenges, particularly in infectious disease outbreaks and antimicrobial resistance. Currently, OM Pharma is actively involved in the prevention of respiratory and urinary tract infections. Their continuous research and development efforts have led to a deeper understanding of how bacterial lysates interact with the immune system, driving investments in new indications and formulations for their products. With its headquarters in Geneva and affiliates in Peru and Switzerland, OM Pharma has established a global presence, making its products available in more than 100 countries through a network of trusted partners. Although the details of their last investment and investors are not available, OM Pharma's commitment to developing innovative solutions for global health challenges positions it as an intriguing prospect for potential venture capital involvement.

Taxonomy: Prevention, Respiratory infections, Urinary tract infections, Vascular diseases, Treatment, Medical, Preventive medicine, Infection prevention, Recurrent infections, Vascular health, Disease prevention, Medical treatment, Health technology, Infectious diseases

No funding data available for OM Pharma yet.

Get notified when OM Pharma raises funding

OM Pharma Alternatives & Competitors

OM Pharma vs
Gedea Biotech AB
Gedea Biotech AB Sweden

Developing antibiotic free treatment for vaginal infections

Grant
16 employees
Biotechnology, Health Care
OM Pharma vs
SaNOtize Research and Development Corp.
SaNOtize Research and Development Corp. Canada

SaNOtize has developed and patented (issued) a Nitric Oxide Releasing Solution platform technology t...

Series B
24 employees
Biotechnology, Life Sciences
OM Pharma vs
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB Sweden

We aim to satisfy unmet medical needs in the premature infant

16 employees
Biotechnology

FAQ About OM Pharma

Transforming Immune Health
OM Pharma was founded in 1937.
OM Pharma is headquartered in Meyrin, Switzerland.
OM Pharma operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
OM Pharma has approximately 557 employees.
Top alternatives and competitors to OM Pharma include Gedea Biotech AB, SaNOtize Research and Development Corp., Infant Bacterial Therapeutics AB, Angiolutions, iFAST Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OM Pharma and Gedea Biotech AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OM Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes